APA (7th ed.) Citation

Petito-da-Silva, T. I., Souza-Mello, V., & Barbosa-da-Silva, S. (2019). Empaglifozin mitigates NAFLD in high-fat-fed mice by alleviating insulin resistance, lipogenesis and ER stress. Molecular and cellular endocrinology, 498, 110539. https://doi.org/10.1016/j.mce.2019.110539

Chicago Style (17th ed.) Citation

Petito-da-Silva, Tamiris Ingrid, Vanessa Souza-Mello, and Sandra Barbosa-da-Silva. "Empaglifozin Mitigates NAFLD in High-fat-fed Mice by Alleviating Insulin Resistance, Lipogenesis and ER Stress." Molecular and Cellular Endocrinology 498 (2019): 110539. https://doi.org/10.1016/j.mce.2019.110539.

MLA (9th ed.) Citation

Petito-da-Silva, Tamiris Ingrid, et al. "Empaglifozin Mitigates NAFLD in High-fat-fed Mice by Alleviating Insulin Resistance, Lipogenesis and ER Stress." Molecular and Cellular Endocrinology, vol. 498, 2019, p. 110539, https://doi.org/10.1016/j.mce.2019.110539.